Do you consider adding a brachytherapy boost to IMRT in patients with cT3b and/or cN1 prostate cancer?
1
1 Answers
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
For T3b disease we do consider a brachy boost.
We look at MRI imaging and based on extent of involvement which usually is to proximal part, and if it appears we can implant that area to full dose, we consider a brachy boost.